Articles

If you are responsible for sourcing, regulatory affairs, or business development for a pharmaceutical manufacturer, the next 5 years will reward the former and punish the latter for good reason. Afric[...]

Pharmaceutical manufacturing has run on batch production for over a century: react, isolate, dry, test, release, repeat. It works. But it is slow, wasteful, variable, and increasingly misaligned with[...]

In November 2025, the WHO Regional Director for the Western Pacific, himself a Tongan physician, published a rare personal account of an antibiotic access failure in Tonga. He described a child brough[...]

As we learned better how to offer APIs with formulated goods to the Pacific Island markets, we faced a challenge for which we couldn’t find a solution in the regulatory textbooks available to us[...]

A Complete Guide for Indian API Exporters and Pacific Pharma Buyers Vanuatu sits at a unique regulatory intersection in 2025-2026. It has no functioning National Regulatory Authority (NRA) to formally[...]

A formulation company makes a large order from a supplier that has a WHO-GMP certificate. The batch order passes in-house QC. Then a regulatory audit triggers a series of problems. The supplier had di[...]

Papua New Guinea (PNG) is an Island country situated in the Oceania region. With a population of approximately 11.8 million, this Island comprises 18 provinces with a total area of 462,840 km². T[...]

In November 2024, the Fiji Pharmaceutical and Biomedical Services director mentioned that there were medical shortages in many health facilities. This primarily comprises medicines that are used for n[...]

If we talk about the years between 2020 to 2023, we are all aware of the changes that come to the global procurement systems and how it impacts the business around the world. In this period, various w[...]